Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine


Yilmaz M. B., Yalta K., Yontar C., Karadas F., Erdem A., Turgut O. O., ...More

CARDIOVASCULAR DRUGS AND THERAPY, vol.21, no.6, pp.431-435, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 6
  • Publication Date: 2007
  • Doi Number: 10.1007/s10557-007-6066-7
  • Journal Name: CARDIOVASCULAR DRUGS AND THERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.431-435
  • Sivas Cumhuriyet University Affiliated: Yes

Abstract

Background Levosimendan is a relatively new cardiac inotropic agent with calcium sensitizing activity. This study was conducted to investigate the effects of levosimendan (L) and dobutamine (D) on renal function in patients hospitalized with decompensated heart failure (HF).